tranylcypromine has been researched along with Substance Withdrawal Syndrome in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (52.94) | 18.7374 |
1990's | 10 (29.41) | 18.2507 |
2000's | 5 (14.71) | 29.6817 |
2010's | 1 (2.94) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumgarten, E; Freudenmann, RW; Gahr, M; Hawlik, AE; Schönfeldt-Lecuona, C | 1 |
Fuls, K; Shaikh, W | 1 |
Bellon, A; Coverdale, JH | 1 |
CASPERSON, P; GARETZ, FK | 1 |
SCHIELE, BC | 1 |
Brunner, H; Friess, E; Pollmächer, T; Wichniak, A | 1 |
Bouvy, PF; Oostervink, F; Touw, DJ | 1 |
Eyer, F; Jetzinger, E; Pfab, R; Zilker, T | 1 |
Hiramori, T; Tagashira, E; Urano, T; Yanaura, S | 1 |
Hiramori, T; Nakao, K; Tagashira, E; Urano, T; Yanaura, S | 2 |
Baxter, LR | 1 |
Draper, RJ; Griffin, N; Webb, MG | 1 |
Hiramori, T; Kuroiwa, Y; Nakao, K; Tagashira, E; Urano, T; Yanaura, S | 1 |
Briggs, NC | 1 |
Briggs, NC; Jefferson, JW | 1 |
Dilsaver, SC; Halle, MT | 1 |
Darmani, NA | 1 |
Bottlender, R; Erfurth, A; Hoff, P; Möller, HJ | 1 |
Albrecht, J; Szelényi, A | 1 |
Ho, IK; Iwamoto, ET; Khanna, S; Loh, HH; Shen, F; Way, EL | 1 |
Ben-Arie, O; George, GC | 1 |
Connor, JD; Drust, EG; Sloviter, RS | 1 |
Mazzi, D; Pallanti, S | 1 |
Gillman, MA; Lichtigfeld, FJ | 1 |
Del Medico, VJ; Dilsaver, SC; Halle, MH | 1 |
Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T | 1 |
Westermeyer, J | 1 |
Sternbach, H | 1 |
Absher, JR; Black, DW | 1 |
Grahame-Smith, DG; Marshall, I | 1 |
Oswald, I | 1 |
Vogel, GW | 1 |
Sargant, W | 1 |
2 review(s) available for tranylcypromine and Substance Withdrawal Syndrome
Article | Year |
---|---|
Sleep, natural and unnatural.
Topics: Amphetamine; Antidepressive Agents; Barbiturates; Brain Chemistry; Dreams; Electroconvulsive Therapy; Electroencephalography; Ethanol; Eye Movements; Female; Heroin; Humans; Isocarboxazid; Male; Monoamine Oxidase Inhibitors; Neurons; Nialamide; Phenelzine; Protein Biosynthesis; Reserpine; Sleep; Sleep Stages; Sleep, REM; Substance Withdrawal Syndrome; Tranylcypromine | 1969 |
REM deprivation. 3. Dreaming and psychosis.
Topics: Anxiety; Behavior; Depression; Dextroamphetamine; Dreams; Drive; Eye Movements; Hallucinations; Humans; Impulsive Behavior; MMPI; Models, Psychological; Personality; Psychoanalytic Theory; Psychological Tests; Psychoses, Alcoholic; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Sleep Deprivation; Substance Withdrawal Syndrome; Tranylcypromine; Trifluoperazine; Wakefulness | 1968 |
32 other study(ies) available for tranylcypromine and Substance Withdrawal Syndrome
Article | Year |
---|---|
Tranylcypromine discontinuation symptoms and withdrawal delirium.
Topics: Antidepressive Agents; Antipsychotic Agents; Delirium; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Substance Withdrawal Syndrome; Tranylcypromine; Treatment Outcome | 2013 |
Tranylcypromine dependence and withdrawal.
Topics: Aged; Humans; Male; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine | 2009 |
Delirium, thrombocytopenia, insomnia, and mild liver damage associated with MAOI withdrawal.
Topics: Adult; Chemical and Drug Induced Liver Injury; Delirium; Female; Humans; Monoamine Oxidase Inhibitors; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Thrombocytopenia; Tranylcypromine | 2009 |
PATIENTS' RESPONSE TO TRANYLCYPROMINE WITHDRAWAL.
Topics: Conduct Disorder; Schizophrenia; Substance Withdrawal Syndrome; Toxicology; Tranylcypromine | 1964 |
THE PARNATE-SPECIFIC PATIENT.
Topics: Depression; Depressive Disorder; Drug Therapy; Humans; Minnesota; Substance Withdrawal Syndrome; Toxicology; Tranylcypromine | 1965 |
Successful suppression of cataplectic attacks with tramadol.
Topics: Aged; Biogenic Monoamines; Cataplexy; Female; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Morpholines; Narcotics; Reboxetine; Receptors, Opioid; Recurrence; Sleep, REM; Substance Withdrawal Syndrome; Tramadol; Tranylcypromine; Treatment Outcome | 2003 |
[Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
Topics: Aged; Depressive Disorder; Female; Hospitalization; Humans; Male; Monoamine Oxidase Inhibitors; Secondary Prevention; Substance Withdrawal Syndrome; Tranylcypromine | 2003 |
Withdrawal from high-dose tranylcypromine.
Topics: Adult; Antidotes; Delirium; Heroin Dependence; Humans; Infusions, Intravenous; Male; Migraine Disorders; Monoamine Oxidase Inhibitors; Physostigmine; Substance Withdrawal Syndrome; Thrombocytopenia; Tranylcypromine | 2008 |
Formation of physical dependence on barbiturates and cerebral monoamines.
Topics: alpha-Methyltyrosine; Animals; Barbital; Barbiturates; Biogenic Amines; Body Weight; Brain; Catecholamines; Fenclonine; Humans; Hydroxyindoleacetic Acid; Male; Methamphetamine; Methyltyrosines; Rats; Rats, Inbred Strains; Serotonin; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine; Tyrosine 3-Monooxygenase | 1983 |
Effects of central monoamine compounds on tranylcypromine-induced barbital-withdrawal convulsions.
Topics: alpha-Methyltyrosine; Animals; Barbital; Barbiturates; Dose-Response Relationship, Drug; Humans; Male; Methyltyrosines; Pentylenetetrazole; Propranolol; Rats; Rats, Inbred Strains; Reserpine; Seizures; Serotonin; Substance Withdrawal Syndrome; Tranylcypromine | 1983 |
Effects of propranolol on barbital dependence formation and withdrawal signs.
Topics: Animals; Anticonvulsants; Barbital; Barbiturates; Drug Interactions; Humans; Male; Propranolol; Rats; Rats, Inbred Strains; Sleep; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors; Tranylcypromine | 1983 |
Reversibility of MAO inhibition.
Topics: Adult; Female; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenelzine; Substance Withdrawal Syndrome; Tranylcypromine | 1984 |
Addiction to tranylcypromine.
Topics: Adult; Aged; Humans; Male; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine | 1981 |
Specific action of tranylcypromine to precipitate barbital withdrawal convulsions.
Topics: Animals; Barbital; Barbiturates; Humans; Monoamine Oxidase Inhibitors; Pentylenetetrazole; Rats; Rats, Inbred Strains; Seizures; Substance Withdrawal Syndrome; Tranylcypromine | 1982 |
Tranylcypromine withdrawal: is it more common than we realize?
Topics: Humans; Mental Disorders; Psychiatric Status Rating Scales; Sleep Wake Disorders; Sleep, REM; Substance Withdrawal Syndrome; Tranylcypromine | 1994 |
Abuse of monoamine oxidase inhibitors.
Topics: Female; Humans; Male; Phenelzine; Sex Factors; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine | 1994 |
Tranylcypromine withdrawal phenomena.
Topics: Acute Disease; Adult; Cognition Disorders; Depressive Disorder; Female; Humans; Male; Monoamine Oxidase Inhibitors; Substance Withdrawal Syndrome; Tranylcypromine | 1993 |
Withdrawal from chronic cocaine administration causes prolonged deficits in L-tryptophan-induced head-twitch response in mice.
Topics: Analysis of Variance; Animals; Cocaine; Drug Administration Schedule; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Motor Activity; Opioid-Related Disorders; Serotonin; Stereotyped Behavior; Substance Withdrawal Syndrome; Time Factors; Tranylcypromine; Tryptophan | 1997 |
[Mianserin-induced hypertension 2 weeks after discontinuation of tranylcypromine].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cardiomyopathy, Dilated; Depressive Disorder; Drug Administration Schedule; Heart Block; Humans; Hypertension; Male; Mianserin; Middle Aged; Recurrence; Risk Factors; Substance Withdrawal Syndrome; Tranylcypromine | 1997 |
Tranylcypromine abuse associated with an isolated thrombocytopenia.
Topics: Adult; Antidepressive Agents; Female; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders; Thrombocytopenia; Tranylcypromine | 1998 |
Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
Topics: Amantadine; Amphetamine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Humans; Hydrazines; Iproniazid; Male; Mice; Mice, Inbred ICR; Morphine Dependence; Motor Activity; Naloxone; Pargyline; Substance Withdrawal Syndrome; Time Factors; Tranylcypromine | 1976 |
A case of tranylcypromine ('Parnate') addiction.
Topics: Drug Tolerance; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine | 1979 |
Effect of morphine on 'wet-dog' shakes caused by cerebroventricular injection of serotonin.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain; Dopamine; Dose-Response Relationship, Drug; Humans; Injections, Intraventricular; Male; Mianserin; Morphine; Naloxone; Norepinephrine; Rats; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome; Tranylcypromine | 1979 |
MDMA (Ecstasy) precipitation of panic disorder.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Agoraphobia; Alcohol Drinking; Amitriptyline; Arousal; Fluvoxamine; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Panic Disorder; Recurrence; Substance Withdrawal Syndrome; Tranylcypromine | 1992 |
Tranylcypromine abuse: cause for concern?
Topics: Delirium; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine | 1992 |
Symptoms of major depression: acute effect of withdrawing antidepressants.
Topics: Adult; Arousal; Chronic Disease; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Substance Withdrawal Syndrome; Tranylcypromine | 1991 |
Neuroleptic malignant syndrome without neuroleptics.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan | 1990 |
Addiction to tranylcypromine (Parnate): a case report.
Topics: Adult; Chronic Disease; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Male; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine | 1989 |
Danger of MAOI therapy after fluoxetine withdrawal.
Topics: Adult; Drug Administration Schedule; Drug Interactions; Female; Fluoxetine; Humans; Substance Withdrawal Syndrome; Tranylcypromine | 1988 |
Tranylcypromine withdrawal delirium.
Topics: Delirium; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Tranylcypromine | 1988 |
Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice.
Topics: Animals; Body Weight; Brain Chemistry; Drug Interactions; Female; Fenclonine; Humans; Kinetics; Mice; Mice, Inbred Strains; Monoamine Oxidase Inhibitors; Morphine; Morphine Dependence; Motor Activity; Naloxone; Serotonin; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan | 1971 |
Safety of combined antidepressant drugs.
Topics: Antidepressive Agents; Dibenzazepines; Drug Synergism; Hallucinations; Humans; Male; Pentobarbital; Psychoses, Alcoholic; Substance Withdrawal Syndrome; Tranylcypromine; Urea | 1971 |